Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:CRNCY OTCMKTS:MCRUF OTCMKTS:OROCF OTCMKTS:PRRFY OTCMKTS:ZLDPF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRNCYCapricorn Energy$6.15-3.0%$6.31$4.67▼$8.93$216.97M0.4947 shs243 shsMCRUFMorgan Advanced Materials$2.95$2.60$2.37▼$3.90N/A0.91486 shsN/AOROCFAllkem$6.80+1.5%$6.80$5.34▼$11.66N/A1.6814,560 shs1,900 shsPRRFYPremier Foods$13.12-0.7%$13.86$10.45▼$14.85$2.28B0.52842 shs387 shsZLDPFZealand Pharma A/S$59.56+4.5%$64.62$54.95▼$141.74$4.23B0.681,111 shs156 shsA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRNCYCapricorn Energy0.00%0.00%+0.63%+6.72%+38.43%MCRUFMorgan Advanced Materials0.00%0.00%+20.80%+24.47%-27.70%OROCFAllkem0.00%0.00%0.00%0.00%0.00%PRRFYPremier Foods-3.58%-3.58%-9.52%+14.87%+36.75%ZLDPFZealand Pharma A/S+4.53%+3.13%-16.24%-4.70%-56.29%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCRNCYCapricorn EnergyN/AN/AN/AN/AN/AN/AN/AN/AMCRUFMorgan Advanced MaterialsN/AN/AN/AN/AN/AN/AN/AN/AOROCFAllkemN/AN/AN/AN/AN/AN/AN/AN/APRRFYPremier FoodsN/AN/AN/AN/AN/AN/AN/AN/AZLDPFZealand Pharma A/SN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCRNCYCapricorn Energy 0.00N/AN/AN/AMCRUFMorgan Advanced Materials 2.00HoldN/AN/AOROCFAllkem 0.00N/AN/AN/APRRFYPremier Foods 3.00BuyN/AN/AZLDPFZealand Pharma A/S 3.80Strong BuyN/AN/ACurrent Analyst Ratings BreakdownLatest CRNCY, ZLDPF, MCRUF, PRRFY, and OROCF Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/7/2025ZLDPFZealand Pharma A/SBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy7/1/2025ZLDPFZealand Pharma A/SBNP ParibasSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy5/27/2025PRRFYPremier FoodsRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeModerate Buy ➝ Hold4/24/2025MCRUFMorgan Advanced MaterialsBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold(Data available from 7/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCRNCYCapricorn Energy$147.80M1.47$2.04 per share3.01$9.90 per share0.62MCRUFMorgan Advanced Materials$1.41BN/A$0.60 per share4.94N/AN/AOROCFAllkem$1.21BN/A$1.10 per share6.16$8.96 per shareN/APRRFYPremier Foods$1.45B1.58$1.20 per share10.90$10.59 per share1.24ZLDPFZealand Pharma A/S$9.09M465.34N/AN/A$17.59 per share3.39Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCRNCYCapricorn Energy$10.60MN/A0.0022.78N/AN/AN/AN/A9/17/2025 (Estimated)MCRUFMorgan Advanced Materials$75.14MN/A0.00∞N/AN/AN/AN/A8/7/2025 (Estimated)OROCFAllkem$441.71MN/A0.0042.50N/AN/AN/AN/AN/APRRFYPremier Foods$159.36MN/A0.0014.26N/AN/AN/AN/AN/AZLDPFZealand Pharma A/S-$156.43M-$2.49N/AN/AN/A-2,127.09%-13.40%-12.28%8/13/2025 (Estimated)Latest CRNCY, ZLDPF, MCRUF, PRRFY, and OROCF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025ZLDPFZealand Pharma A/S-$0.77-$0.67+$0.10-$0.67$248.61 million$1.14 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCRNCYCapricorn EnergyN/AN/AN/AN/AN/AMCRUFMorgan Advanced MaterialsN/AN/AN/AN/AN/AOROCFAllkemN/AN/AN/AN/AN/APRRFYPremier Foods$0.161.22%N/AN/AN/AZLDPFZealand Pharma A/SN/AN/AN/AN/AN/ALatest CRNCY, ZLDPF, MCRUF, PRRFY, and OROCF DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/19/2025PRRFYPremier Foods$0.16081.17%6/27/20256/30/20258/8/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCRNCYCapricorn Energy0.222.242.19MCRUFMorgan Advanced MaterialsN/AN/AN/AOROCFAllkem0.082.522.23PRRFYPremier Foods0.231.511.13ZLDPFZealand Pharma A/S0.0325.1025.07Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCRNCYCapricorn EnergyN/AMCRUFMorgan Advanced MaterialsN/AOROCFAllkemN/APRRFYPremier FoodsN/AZLDPFZealand Pharma A/SN/AInsider OwnershipCompanyInsider OwnershipCRNCYCapricorn Energy0.74%MCRUFMorgan Advanced MaterialsN/AOROCFAllkemN/APRRFYPremier FoodsN/AZLDPFZealand Pharma A/SN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCRNCYCapricorn Energy19035.28 million35.02 millionNot OptionableMCRUFMorgan Advanced Materials8,694N/AN/ANot OptionableOROCFAllkem1,350N/AN/ANot OptionablePRRFYPremier Foods4,000173.76 millionN/ANot OptionableZLDPFZealand Pharma A/S34071.02 millionN/ANot OptionableCRNCY, ZLDPF, MCRUF, PRRFY, and OROCF HeadlinesRecent News About These CompaniesZealand Pharma A/S (OTCMKTS:ZLDPF) Stock Rating Upgraded by BarclaysJuly 9 at 7:35 AM | marketbeat.comZealand Pharma A/S (OTCMKTS:ZLDPF) Shares Gap Up - Here's WhyJuly 8 at 3:08 PM | marketbeat.comZealand Pharma A/S (OTCMKTS:ZLDPF) Rating Increased to Strong-Buy at BNP ParibasJuly 4, 2025 | marketbeat.comFinancial Review: Zealand Pharma A/S (ZLDPF) & Its CompetitorsJuly 3, 2025 | americanbankingnews.comZealand Pharma A/S (OTCMKTS:ZLDPF) Sets New 52-Week Low - Time to Sell?June 30, 2025 | marketbeat.comZealand Pharma A/S (OTCMKTS:ZLDPF) Reaches New 52-Week Low - Should You Sell?June 24, 2025 | marketbeat.comZealand Pharma A/S (OTCMKTS:ZLDPF) Shares Gap Down - Here's WhyJune 20, 2025 | marketbeat.comZealand Pharma A/S (OTCMKTS:ZLDPF) Sets New 52-Week Low - Here's What HappenedJune 17, 2025 | marketbeat.comCantor Fitzgerald Comments on OTCMKTS:ZLDPF FY2026 EarningsJune 12, 2025 | marketbeat.comFY2025 EPS Forecast for Zealand Pharma A/S Raised by AnalystJune 11, 2025 | marketbeat.comZealand CEO: Oral weight loss meds are not the future for treating obesityMay 15, 2025 | seekingalpha.comZealand Pharma A/S (ZLDPF) Q1 2025 Earnings Call TranscriptMay 9, 2025 | seekingalpha.comZealand Pharma AS (ZLDPF) Q1 2025 Earnings Call Highlights: Strategic Collaborations and ...May 9, 2025 | finance.yahoo.comInside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambitMay 2, 2025 | cnbc.comZealand Pharma AS (ZLDPF) Stock Jumps 8.0%: Will It Continue to Soar?May 1, 2025 | zacks.comZealand Pharma begins mid-stage trial for obesity drug candidate in people with type 2 diabetesApril 24, 2025 | reuters.comZealand Pharma appoints Utpal Singh as Chief Scientific OfficerApril 23, 2025 | contractpharma.comCZealand Pharma appoints Utpal Singh as CSOApril 23, 2025 | markets.businessinsider.comZealand Pharma Hires Lilly Executive as Biotech Ramps Up in ObesityApril 23, 2025 | msn.comZealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2025April 19, 2025 | finance.yahoo.comZealand Pharma Goes on Hiring Spree as It Gears Up for Obesity Tie-Up With RocheApril 11, 2025 | wsj.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCRNCY, ZLDPF, MCRUF, PRRFY, and OROCF Company DescriptionsCapricorn Energy OTCMKTS:CRNCY$6.15 -0.19 (-3.00%) As of 12:22 PM EasternCapricorn Energy PLC, an independent energy company, engages in the exploration, development, production, and sale of oil and gas worldwide. It holds a portfolio of exploration, development, and production assets in Mexico and Egypt. The company was formerly known as Cairn Energy PLC and changed its name to Capricorn Energy PLC in December 2021. Capricorn Energy PLC was founded in 1980 and is headquartered in Edinburgh, the United Kingdom.Morgan Advanced Materials OTCMKTS:MCRUF$2.95 0.00 (0.00%) As of 07/7/2025Morgan Advanced Materials plc operates as a materials science and application engineering company primarily the United Kingdom. It serves customers in the industrial, transportation, petrochemical and chemical, energy, semiconductor and electronics, healthcare, and security and defense markets. The company was formerly known as The Morgan Crucible Company plc and changed its name to Morgan Advanced Materials plc in March 2013. Morgan Advanced Materials plc was founded in 1856 and is headquartered in Windsor, the United Kingdom.Allkem OTCMKTS:OROCF$6.80 +0.10 (+1.49%) As of 01/8/2024Allkem Limited engages in the production and sale of lithium and boron in Argentina. Its flagship project is the Olaroz Lithium Facility located in Jujuy province in northern Argentina. Allkem Limited was incorporated in 2005 and is headquartered in Brisbane, Australia.Premier Foods OTCMKTS:PRRFY$13.12 -0.09 (-0.68%) As of 10:39 AM EasternPremier Foods plc, together with its subsidiaries, manufactures and distributes branded and own label food products in the United Kingdom, other European countries, and internationally. The company operates through Grocery, Sweet Treats, and international segments. It offers a portfolio of product categories, including flavorings and seasonings under the Bisto, OXO, Paxo, and Saxa brands; cooking sauces and accompaniments under the Sharwood's, Loyd Grossman, Spice Tailor and Homepride brands; quick meals, snacks, and soups under the Batchelors and Smash brands; ambient desserts under the Ambrosia, Bird's, and Angel Delight brands; and ambient cakes under the Mr Kipling and Cadbury brands. The company also provides dumplings under the Atora brand name; plain flour under the Be-Ro brand; dried milk under the Marvel brand name; plain and self-raising flour under the McDougalls brand; and plant based food under the Plantastic brand name. It offers its products through supermarkets, discounters, convenience stores, and wholesale and food service facilities, as well as through e-commerce channels. The company was founded in 1975 and is headquartered in Saint Albans, the United Kingdom.Zealand Pharma A/S OTCMKTS:ZLDPF$59.56 +2.58 (+4.53%) As of 07/8/2025 10:48 AM EasternZealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company offers Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon that is in Phase III clinical trials for treating congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SoundHound Rises as Short Sellers Exit and AI Demand Grows Amazon's Prime Day Pullback Meets Bullish Golden Cross Signal Palantir’s Revenue Surge to $1B: Growth vs. Valuation Chime Financial: Analysts Ring In—And It’s a Buy Is Fortinet Ready to Break Out After Months of Consolidation? Robinhood Stock Gets 5 Price Target Upgrades, Signaling Upside AST SpaceMobile: Is Market Noise Drowning Out a $100M Signal? CoreWeave's $9 Billion Power Play for Core Scientific Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
